Charles Schwab Investment Management Inc Gossamer Bio, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,241,979 shares of GOSS stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,241,979
Previous 1,228,077
1.13%
Holding current value
$1.73 Million
Previous $1.22 Million
8.07%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$25.5 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$25.1 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.9 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$12.2 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$11.2 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $131M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...